June 27th 2025, 8:00pm
By Mark Daniels
Mark Daniels, 83, credits CAR T-cell therapy and compassionate care for helping him overcome lymphoma and endure the isolating treatment toll.
June 27th 2025, 7:00pm
By Ryan Scott
June brought major prostate cancer updates, and CURE is sharing the latest FDA approvals, label expansions, and emerging data on the role of AI in care.
June 27th 2025, 5:00pm
By Laura Yeager
After having a double mastectomy to rid myself of cancer, I’m less picky about how I look and won’t be wearing uncomfortable shapewear for a wedding.
June 27th 2025, 4:00pm
Label updates have been approved by the FDA for the CAR T-cell therapies Breyanzi and Abecma in large B cell lymphoma and multiple myeloma, respectively.
June 27th 2025, 3:00pm
By Spencer Feldman
CAR T-cell therapy may cure up to 40% of patients with lymphoma and is an option for those who can’t receive transplants, says Dr. André Goy.
June 27th 2025, 1:00pm
By Dr. Lydia Scarfò
An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns, per Dr. Lydia Scarfò.
June 26th 2025, 9:00pm
By Brian Sluga
I was diagnosed with testicular cancer at 20. I’ve learned to embrace the pauses in life and stand proud as a survivor who won’t be ignored.
June 26th 2025, 8:00pm
By Valarie Traynham
Valarie Traynham shares what survivorship means to her, and how the definition has evolved after her diagnosis, during National Cancer Survivors Month.
June 26th 2025, 7:00pm
June brought major blood cancer updates, and CURE is sharing the latest in myelofibrosis treatment and FDA breakthroughs, as well as survivorship news.
June 26th 2025, 5:00pm
Dr. Ravi Munver explained that, for patients who are recently diagnosed with prostate cancer, it is important to explore treatment option with their care.
June 26th 2025, 4:00pm
By Sue McCarthy
I entered remission from lung cancer 5.5 years ago, but faced a tough road readjusting, with ongoing physical, mental and emotional challenges.
June 26th 2025, 3:00pm
The FDA has granted priority review to an application for Revuforj for the treatment of relapsed or refractory mutant NPM1 acute myeloid leukemia.
June 26th 2025, 1:00pm
Greek yogurt, egg salad, avocado and mac and cheese are easy-to-swallow, high-calorie foods that can help patients maintain strength during cancer treatment.
June 25th 2025, 9:00pm
By Morgan Newman
Cancer survivor Morgan Newman shares how self-advocacy helped her overcome barriers to care and find the support she needed after treatment.
June 25th 2025, 8:00pm
By Dr. Andre Henri Goy
Dr. Andre Henri Goy shared how CAR T-cell therapy led a retired pilot with lymphoma into remission, showing the impact of personalized treatment decisions.
Understanding Your Diagnosis of Bile Duct Cancer
Understanding Your Stage 2 Uterine (Endometrial) Cancer
Top Blood Cancer Stories from October: Key Updates for Patients
Expert Explains Need for Better Outcomes in Resectable Lung Cancer